These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5912432)

  • 1. N-hydroxy-2-fluorenylbenzamide, an arylhydroxamic acid with high carcinogenic activity.
    Gutmann HR; Galitski SB; Foley WA
    Nature; 1966 Jan; 209(5019):202-3. PubMed ID: 5912432
    [No Abstract]   [Full Text] [Related]  

  • 2. [An immunologic analysis of rat sarcomas induced by administration of extracts from human tumors].
    Bashkaev IS; Ageenko AI
    Biull Eksp Biol Med; 1967 Jun; 63(6):85-8. PubMed ID: 4988457
    [No Abstract]   [Full Text] [Related]  

  • 3. The conversion of noncarcinogenic aromatic amides to carcinogenic arylhydroxamic acids by synthetic N-hydroxylation.
    Gutmann HR; Galitski SB; Foley WA
    Cancer Res; 1967 Aug; 27(8):1443-55. PubMed ID: 6047873
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-reacting tumor-associated antigen(s) of adenovirus type 9-induced fibroadenomas and a chemically induced mammary carcinoma in rats.
    Ankerst J; Steele G; Sjögren HO
    Cancer Res; 1974 Aug; 34(8):1794-800. PubMed ID: 4367178
    [No Abstract]   [Full Text] [Related]  

  • 5. Rat mammary gland carcinogenesis after local injection of N-hydroxy-N-acyl-2-aminofluorenes: relationship to metabolic activation.
    Allaben WT; Weeks CE; Weis CC; Burger GT; King CM
    Carcinogenesis; 1982; 3(3):233-40. PubMed ID: 7083466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carcinogenic and mutagenic properties of N-hydroxy-aminonaphthalenes.
    Belman S; Troll W; Teebor G; Mukai F
    Cancer Res; 1968 Mar; 28(3):535-42. PubMed ID: 4867926
    [No Abstract]   [Full Text] [Related]  

  • 7. Mammary and other tumors as a response to radiation and multiple stresses.
    Warren S; Brown CE
    Arch Pathol Lab Med; 1978 May; 102(5):224-6. PubMed ID: 580557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxidative metabolism of carcinogenic N-arylhydroxamic acids: implications for tumorigenesis.
    Malejka-Giganti D; Ritter CL
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):75-81. PubMed ID: 7889863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The carcinogenicity of fluorenylhydroxamic acids and N-acetoxy-N-fluorenylacetamides for the rat as related to the reactivity of the esters toward nucleophiles.
    Yost Y; Gutmann HR; Rydell RE
    Cancer Res; 1975 Feb; 35(2):447-59. PubMed ID: 1109807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylhydroxamic acid N,O-acyltransferase. Apparent suicide inactivation by carcinogenic N-arylhydroxamic acids.
    Banks RB; Hanna PE
    Biochem Biophys Res Commun; 1979 Dec; 91(4):1423-9. PubMed ID: 526312
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of interaction among three carcinogens on rat mammary carcinogenesis in a factorially designed experiment.
    Shellabarger CJ; Machado SG; Holtzman S; Stone JP
    J Natl Cancer Inst; 1987 Sep; 79(3):549-54. PubMed ID: 3114536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat mammary neoplasia following deposition of plutonium.
    Sanders CL
    Health Phys; 1974 Dec; 27(6):592-3. PubMed ID: 4436066
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of experimental hypothyroidism on the development of mastopathia and tumors of the mammary gland in rats].
    Ird EA
    Probl Endokrinol Gormonoter; 1966; 12(1):99-102. PubMed ID: 5979826
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of mammary fibroadenomas in rats by adenovirus type 9.
    Ankerst J; Jonsson N; Kjellén L; Norrby E; Sjögren HO
    Int J Cancer; 1974 Mar; 13(3):286-90. PubMed ID: 4822103
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of the liver in the development of dyshormonal diseases of the mammary glands in rats].
    Ird EA; Smirnova IO
    Biull Eksp Biol Med; 1978 Dec; 86(12):713-5. PubMed ID: 728615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THE CARCINOGENIC ACTIVITIES OF N-HYDROXY-2-ACETYLAMINOFLUORENE AND ITS METAL CHELATES AS A FUNCTION OF RETENTION AT THE INJECTION SITE.
    POIRIER MM; MILLER JA; MILLER EC
    Cancer Res; 1965 May; 25():527-33. PubMed ID: 14297490
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cancerogenic power of urethane in Sprague rats].
    Adenis L; Demaille A; Driessens J
    C R Seances Soc Biol Fil; 1968; 162(2):458-61. PubMed ID: 4303205
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutron-induced mammary neoplasms in the rat.
    Vogel HH; Zaldívar R
    Cancer Res; 1972 May; 32(5):933-8. PubMed ID: 5017741
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of low-frequency electromagnetic fields on the development of experimental mammary tumors].
    Beniashvili DSh; Bilanishvili VG; Menabde MZ
    Vopr Onkol; 1991; 37(9-10):937-41. PubMed ID: 1842653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.